Back to results
CompletedPhase 2

Peroral Levosimendan in Chronic Heart Failure

NCT00130884

What is this trial?

Generating plain-language summary...

Am I eligible?

Generating eligibility summary...

What's involved?

Summarizing study design...

Where and how to apply

Primary location

Helsinki University Central Hospital

Helsinki, Finland

View on ClinicalTrials.gov
Peroral Levosimendan in Chronic Heart Failure — TrialFind